Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)

Marigdalia K Ramirez-Fort; Casey K Gilman; Jacob S Alexander; Barbara Meier-Schiesser; Arjan Gower; Mojtaba Olyaie; Neel Vaidya; Kiarash Vahidi; Yuxin Li; Christopher S Lange; Migdalia Fort; Corinne Deurdulian

doi:10.3389/fmed.2023.1304718

Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)

Front Med (Lausanne). 2024 Feb 9:10:1304718. doi: 10.3389/fmed.2023.1304718. eCollection 2023.

Authors

Marigdalia K Ramirez-Fort^{1

2

3}, Casey K Gilman^{1

4}, Jacob S Alexander^{1

4}, Barbara Meier-Schiesser⁵, Arjan Gower³, Mojtaba Olyaie^{2

3}, Neel Vaidya², Kiarash Vahidi², Yuxin Li^{2

3}, Christopher S Lange^{1

6}, Migdalia Fort¹, Corinne Deurdulian^{2

3

7}

Affiliations

¹ BioFort, Guaynabo, Puerto Rico.
² Veterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United States.
³ University of California at Los Angeles (UCLA) Health System, Los Angeles, CA, United States.
⁴ San Juan Bautista School of Medicine, Caguas, Puerto Rico.
⁵ University Hospital Zürich, Zürich, Switzerland.
⁶ Department of Radiology, SUNY Downstate Health Sciences University, Brooklyn, NY, United States.
⁷ University of Southern California, Los Angeles, CA, United States.

No abstract available

Keywords: disease-inclusive language; folate hydrolase-1; gender-inclusive language; prostate-specific membrane antigen; theragnostic target.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. BioFort and the University Hospital of Zurich Library provided funding for the journal publishing fees. The funders were not involved in the study design, analysis, interpretation of data, the writing of this article or in the decision to submit it for publication.